LeonaBio (LONA) Total Current Liabilities (2019 - 2026)

LeonaBio (LONA) has 8 years of Total Current Liabilities data on file, last reported at $6.7 million in Q1 2026.

• Quarterly Total Current Liabilities rose 21.38% year-over-year to $6.7 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $6.7 million (up 21.38% YoY) and the FY2025 annual result came in at $47.5 million, up 261.65% from the prior year.
• Total Current Liabilities retreated to $6.7 million in Q1 2026 per LONA's latest filing, from $47.5 million in the prior quarter.
• Across five years, Total Current Liabilities topped out at $47.5 million in Q4 2025 and bottomed at $2.8 million in Q3 2025.
• The 5-year median for Total Current Liabilities is $20.2 million (2023), against an average of $18.2 million.
• Peak annual rise in Total Current Liabilities reached 261.65% in 2025, while the deepest fall reached 89.96% in 2025.
• Tracing LONA's Total Current Liabilities over 5 years: stood at $21.4 million in 2022, then jumped by 34.57% to $28.8 million in 2023, then slumped by 54.46% to $13.1 million in 2024, then jumped by 261.65% to $47.5 million in 2025, then plunged by 85.97% to $6.7 million in 2026.
• Per Business Quant, the three latest LONA Total Current Liabilities figures stand at $6.7 million (Q1 2026), $47.5 million (Q4 2025), and $2.8 million (Q3 2025).

Peer Comparison